(Q44171258)

30 November 2017

Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice (English)

1 reference

30 November 2017

0 references

Rafaela L Ribeiro

1

1 reference

PubMed ID

12369258

30 November 2017

Thereza C M De Lima

series ordinal

2

1 reference

PubMed ID

12369258

30 November 2017

language of work or name

1 reference

1 June 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

30 November 2017

1 reference

30 November 2017

26

1 reference

30 November 2017

5

1 reference

30 November 2017

861-869

1 reference

Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Actions of substance P on rat neostriatal neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Neurochemical mechanisms of the defensive behavior in the dorsal midbrain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Neuronal NK3-receptors in guinea-pig ileum and taenia caeci: in vitro characterization by their first non-peptide antagonist, SR142801

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Central tachykinins: mediators of defence reaction and stress reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

A note on a simple apparatus for detecting neurological deficit in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Neuropeptide-containing neurons of the cerebral cortex are also GABAergic

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

The 'peptoid' approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Intracerebroventricular injections in mice. Some methodological refinements

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

1 reference

7 January 2021

Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Tachykinin receptors: a radioligand binding perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Mammalian Tachykinin Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Involvement of GABA(A)-benzodiazepine receptor in the anxiolytic effect induced by hexanic fraction of Rubus brasiliensis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

NK-3 receptors are expressed on mouse striatal gamma-aminobutyric acid-ergic interneurones and evoke [(3)H] gamma-aminobutyric acid release

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Receptors for substance P and related neurokinins

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Tachykinin NK(3)receptor involvement in anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Animal models of anxiety: an ethological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Highly selective agonists for substance P receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900331-1

7 January 2021

10.1016/S0278-5846(01)00331-1

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12369258